APEX1 and eye disorder: Approaches such as targeting the redox function of APE1/Ref-1 may be the future of neovascular eye disease therapeutics, as the redox activity influences multiple relevant pathways involved in angiogenesis, inflammation, stress response and cell survival (Figure 1E).